Foley Hoag Represents Alere on $270M-Plus Deal to Acquire eScreen

March 7, 2012

Foley Hoag LLP represented Alere Inc. as it entered into a binding agreement to purchase eScreen Inc., a technology firm that specializes in toxicology screening and employee health products and services.

Alere, a diagnostics and health management company based in Waltham, Mass., agreed to purchase eScreen for a base price of $270 million, with potential for contingent consideration of up to an additional $70 million. The deal is subject to customary closing conditions.

Kansas-based eScreen deploys an automated platform and FDA-cleared reader for the collection, provision, management and reporting of regulated and non-regulated urine drug screens. The company has operations in Phoenix and sales and service offices in Richmond, Va., and Calgary, Canada.

Alere’s global products and services, as well as its new product development efforts, focus on cardiology, women’s health, infectious disease, oncology and toxicology.

Foley Hoag partner Mark Haddad, deputy chair of the firm’s Business Department, led the legal team that represented Alere. He was joined by associates Mary Beth Noonan Heath, Prithvi Tanwar, Erica Rice and Mike Nelson.

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and investment management fields, and in cross-border disputes. Our professionals  possess the skills  and experience to provide exceptional senior level service to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.